Aqueous solvent system for the solubilization of azole compounds

European Journal of Pharmaceutical Sciences

Volumn 36, Issue 2-3, 2009, Pages 352-358

  Kovács, Kristóf ^a   Stampf, György ^a   Klebovich, Imre ^a   Antal, István ^a   Ludányi, Krisztina ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Azole; Co solvent; Parenteral; pH adjuster; Solubility enhancement; Surfactant

Indexed keywords

ACETIC ACID; ALCOHOL; GLUCONIC ACID; GLYCEROL; ITRACONAZOLE; KETOCONAZOLE; MACROGOL 400; MICONAZOLE; PHOSPHATE; POLYSORBATE 20; POLYSORBATE 60; POLYSORBATE 80; PROPYLENE GLYCOL; SOLVENT; SURFACTANT; TAUROCHOLIC ACID;

ANTIFUNGAL ACTIVITY; AQUEOUS SOLUTION; ARTICLE; DRUG MECHANISM; DRUG SOLUBILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PH; PRIORITY JOURNAL;

ACETATES; AZOLES; CALCIUM GLUCONATE; ETHANOL; GLYCEROL; HYDROGEN-ION CONCENTRATION; ITRACONAZOLE; KETOCONAZOLE; MICONAZOLE; PHOSPHORIC ACIDS; POLYETHYLENE GLYCOLS; POLYSORBATES; PROPYLENE GLYCOL; SOLUBILITY; SOLVENTS; SURFACE-ACTIVE AGENTS; WATER;

EID: 58149164902     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2008.10.007     Document Type: Article

References (36)

1. Agrawal S., Pancholi S.S., Jain N.K., and Agrawal G.P. Hydrotropic solubilization of nimesulide for parenteral administration. Int. J. Pharm. 274 (2004) 149-155
2. Alvarez-Núñez F.A., and Yalkowsky S.H. Buffer capacity and precipitation control of pH solubilized phention formulations. Int. J. Pharm. 185 (1999) 45-49
3. Barillaro V., Bertholet P., and de Hassonville S.H. Effect of acidic ternary compounds on the formation of miconazole/cyclodextrin inclusion complexes by means of supercritical carbon dioxide. J. Pharm. Pharm. Sci. 7 3 (2004) 378-388
4. Budai M., Szabó Zs., Zimmer A., Szögyi M., and Gróf P. Studies on molecular interactions between nalidixic acid and liposomes. Int. J. Pharm. 279 1/2 (2004) 67-79
5. Bundgaard H., Falch E., Pedersen S.B., and Nielsen G.H. Allopurinol prodrugs. IV. Improved rectal and parenteral delivery of allopurinol using the prodrug approach as evaluated in rabbits. Int. J. Pharm. 27 (1985) 71-80
6. Caporal-Gauthier J., Nivet J.M., and Algrande P. Guide de validation analytique: rapport d'une commision SFSTP. I. Methodologie. STP Pharma. Pratiques. 2 4 (1992) 205-206
7. Duchene D., Wouessidjewe D., and Ponchel G. Cyclodextrins and carrier systems. J. Control. Release 62 (1999) 263-268
8. Gelderblom H., Verweij J., Nooter K., and Sparreboom A. Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation. Eur. J. Cancer 37 (2001) 1590-1598
9. Godefroi, E.F., Herees, J., inventors, Janssen Pharmaceutica, assignee, 1969. Antifungal and antibacterial compositions of certain imidazols and methods of using same. US Patent 3,717,655. 23 July.
10. Howrie D.L., Ptachcinski R.J., Griffith B.P., Hardesty R.J., Rosenthal J.T., Burckart G.J., and Venkataramanan R. Anaphylactoid reactions associated with parenteral cyclosporine use: possible role of Cremophor EL. Drug Intell. Clin. Pharm. 19 (1985) 425-427
11. Kauffman A., and Carver P. Use of azoles for systemic antifungal therapy. Adv. Pharmacol. 39 (1997) 147-189
12. Kawakami K., Oda N., Miyoshi K., Funaki T., and Ida Y. Solubilization behavior of a poorly soluble drug under combined use of surfactants and cosolvents. Eur. J. Pharm. Sci. 28 (2006) 7-14
13. Lamas M.C., Villaggi L., Nocito I., Bassani G., Leonardi D., Pascutti F., Serra E., and Salomon C.J. Development of parenteral formulations and evaluation of the biological activity of the trypanocide drug benznidazole. Int. J. Pharm. 307 (2006) 239-243
14. Lee Y., Zocharski P.D., and Samas B. An intravenous formulation decision tree for discovery compound formulation development. Int. J. Pharm. 253 (2003) 111-119
15. Li P., Tabibi S.E., and Yalkowsky S.H. Solubilization of ionized and un-ionized flavopiridol by ethanol and polysorbate 20. J. Pharm. Sci. -U.S. 88 5 (1999) 507-509
16. Li P., Tabibi S.E., and Yalkowsky S.H. Solubilization of flavopiridol by pH control combined with cosolvents, surfactants, or complexants. J. Pharm. Sci. -U.S. 88 9 (1999) 945-947
17. Liu R. Water-Insoluble Drug Formulation. 2nd ed. (2008), CRC Press, Suite, NW/Boca Raton, FL
18. Medlicott N.J., Foster K.A., Audus K.L., Gupta S., and Stella V.J. Comparison of the effects of potential vehicles for poorly water soluble anticancer drugs (organic cosolvents and cyclodextrin solutions) on cultured endothelial cells (HUV-EC). J. Pharm. Sci. 87 (1998) 1138-1143
19. Millard J.W., Alvarez-Nunez F.A., and Yalkowsky S.H. Solubilization by cosolvents. Establishing useful constants for the log-linear model. Int. J. Pharm. 245 (2002) 153-166
20. Nema S., Brendel R.J., and Washkuhn R. Excipients: parenteral dosage forms and their role. In: Swarbrick J., and Boylan J.C. (Eds). Encyclopedia of Pharmaceutical Technology. 2nd ed. (2006), Marcel Dekker, Inc., New York 1623-1645
21. Ni N., Sanghvi T., and Yalkowsky S.H. Solubilization and preformulation of carbendazim. Int. J. Pharm. 244 (2002) 99-104
22. Pedersen M., Edelsten M., Nielsen V.F., Scarpellini A., Skytte S., and Slot C. Formation and antimycotic effect of cyclodextrin inclusion complexes of econazole and miconazole. Int. J. Pharm. 90 3 (1993) 247-254
23. Piel G., Evrard B., Fillet M., Llabres G., and Delattre L. Development of a non-surfactant parenteral formulation of miconazole by the use of cyclodextrins. Int. J. Pharm. 169 (1998) 15-22
24. Piel G., Hayette M.P., Pavoni E., Evrard B., Van Hees T., De Hasonville S.H., De Mol P., and Delattre L. In vitro comparison of the antimycotic activity of a miconazole-HP-ß-cyclodextrin solution with a miconazole surfactant solution. J. Antimicrob. Chemoth. 48 (2001) 83-87
25. Rangel-Yagui C.O., Pessoa-Jr A., and Tavares L.C. Micellar solubilization of drugs. J. Pharm. Pharm. Sci. 8 2 (2005) 147-163
26. Richardson M.D., and Jones B.L. Therapeutic Guidelines in Systemic Fungal Infections. 3rd ed. (2004), Current Medical Literature Books Remedica Publishing Ltd., London, England
27. Sawyer P.R., Brogden R.N., Pinder R.M., Speight T.M., and Avery G.S. Miconazole: a review of its antifungal activity and therapeutic efficacy. Drugs 9 (1975) 406-423
28. Strickley R.G. Parenteral formulations of small molecules therapeutics marketed in the United States-Part I. PDA J. Pharm. Sci. Technol. 53 6 (1999) 324-349
29. Strickley R.G. Solubilizing excipients in oral and injectable formulations. Pharm. Res. 21 2 (2004) 201-230
30. Sugiyama, M., Okita, A., Seki, J., inventors, Nippon Shinyaku Co. Ltd., assignee, 1994. Drug carriers. US Patent 5,651,991. 22 February.
31. Sweetana S., and Akers M.J. Solubility principles and practice for parenteral drug dosage form development. J. Pharm. Sci. Technol. 50 5 (1999) 330-342
32. Torrado S., Torrado S., Cadorniga R., and Torrado J.J. Formulation parameters of albendazole solution. Int. J. Pharm. 140 (1996) 45-50
33. Wade A., and Weller P.J. Handbook of Pharmaceutical Excipients. 2nd ed. (1994), Pharmaceutical Press and American Pharmacists Association, London-Washington
34. Wheeler, J.J., Bally, M.B., inventors, Inex Pharmaceuticals Corp., assignee, 1995. Stable microemulsions for hydrophobic compound delivery. US Patent 5,478,860. 26 December.
35. Yalkowsky S.H. Solubility and Solubilization in Aqueous Media (1999), Oxford University Press, New York, NY
36. Zhang J.A., Anyarambhatla G., Ma L., Ugwu S., Xuan T., Sardone T., and Ahmad I. Development and characterization of a novel Cremophor EL free liposome-based paclitaxel (LEP-ETU) formulation. Eur. J. Pharm. Biopharm. 59 (2005) 177-187